3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive Advisor to CEO After 25 Years of Pioneering Innovation
COPENHAGEN, Denmark, Sept. 12, 2025 /PRNewswire/ -- 3Shape today announced a leadership transition that honors one of its most influential innovators. After 25 years at the forefront of 3Shape's journey, Rune Fisker, Senior Vice President of Product Strategy, will step down from his current role and transition into a new position as External Executive Advisor to CEO Jacob Paulsen. Since...
Nexus Aesthetic Clinic Founder Dr. Samantha Tay Advocates for Enhanced Patient Safety in Aesthetic Medicine
Founder of Nexus Aesthetic Clinic addresses public concerns about injectables and highlights the importance of professional oversight. SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- Amid a growing public conversation about the safety and efficacy of aesthetic procedures, Dr. Samantha Tay, founder of Nexus Aesthetic Clinic, is emphasizing the importance of prioritizing patient safety through direct, doctor-led care. By personally conducting...
Prioritizing Quality and Patient Safety with Digital Transformation, RS Pondok Indah Group Becomes First in Indonesia to Achieve HIMSS EMRAM Stage 7
Setting new standards in healthcare quality and patient safety through digital transformation. JAKARTA, Indonesia, Sept. 12, 2025 /PRNewswire/ -- RS Pondok Indah Group (Pondok Indah Hospital Group) has made history as the first hospital group in Indonesia to achieve the HIMSS Electronic Medical Record Adoption Model (EMRAM) Stage 7, the world's highest quality standard for assessing digital maturity and...
Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig
NANJING, China, Sept. 12, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in a Phase 1b/II clinical trial (NCT07099430) evaluating Opamtistomig (LBL-024, PD-L1/4-1BB bispecific antibody) as monotherapy or in combination with other agents for the first-line treatment of advanced melanoma. Opamtistomig, a uniquely...
Smartee and Shanghai Ninth People’s Hospital Win First Prize at Shanghai Science and Technology Progress Awards
SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Smartee Denti-Technology, a global innovator in invisible orthodontic solutions, together with Shanghai Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, has been awarded the First Prize of the Shanghai Science and Technology Progress Award. This prestigious recognition highlights the two institutions' joint achievements in advancing precision surgery for complex...
The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration
SUZHOU, China, Sept. 12, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK), has been accepted by the National Medical Products Administration (NMPA). KN026 has...
Amazfit Announces Olympic Medalist Grant Fisher as New Brand Ambassador
Elite distance runner joins Amazfit's growing athlete team and will play an active role in product testing and innovation MILPITAS, Calif., Sept. 12, 2025 /PRNewswire/ -- Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced two-time Olympic medalist and American record holder Grant Fisher as the newest addition to its roster of athlete ambassadors....
Psoriatic Disease To Take Center Stage at the UN General Assembly: IFPA Calls for Greater Recognition of Psoriatic Disease During UN High-Level Meetings
STOCKHOLM, Sept. 12, 2025 /PRNewswire/ -- The International Federation of Psoriasis Associations (IFPA) spotlights psoriatic disease at the upcoming UNGA 80 in New York, where world leaders are expected to adopt a new Political Declaration on noncommunicable diseases (NCDs), mental health and well-being. Frida Dunger - Executive Director of IFPA...
Zhimeng Biopharma’s Investigational Drug Approved to Initiate Phase 2 Epilepsy Clinical Trial in China
SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma") announced that its self-developed novel next-generation KCNQ2/3 potassium channel opener, CB03-154, has recently received clinical trial approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to initiate a Phase 2 clinical trial in China for refractory epilepsy. This follows the...
Datasea Secures Landmark Agreement for First Acoustic Wearable Technology Contract, Marking Entry into the $1 Trillion Market
Driving the Commercialization of Acoustic Technology in Smart Health Wearables through Solution-Based Service Delivery BEIJING, Sept. 11, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS), a Nevada-based technology company specializing in acoustic high-tech products and AI multimodal digital solutions, today announced that its VIE entity in China, Shuhai Jingwei (Shenzhen) Information Technology...
